Prime Minister (Sir ): The Chair of the UK Covid-19
Inquiry has today published the Inquiry's Module 4 report, which
examines the development and implementation of vaccines and
therapeutics during the pandemic.
The Chair recognises that the UK authorised and deployed
effective vaccines and treatments at unprecedented speed. These
achievements reflect the strength of the UK's world-leading life
sciences sector, the universal public health system in each of
the four nations which allowed whole population delivery of
vaccines, and the extraordinary dedication of health and care
staff. They also speak to the collective resolve of the public in
coming forward to be vaccinated.
I would like to thank all those involved in this national effort
– scientists, researchers, regulators, NHS and social care staff,
volunteers, and all those who supported the rollout of vaccines
and treatments at pace.
The Inquiry identifies the following areas for further work:
strengthening manufacturing capability, sustaining investment in
research and development, and developing the Vaccine Damage
Payment Scheme. It also notes disparities in vaccine uptake among
certain communities and the risk of vaccine hesitancy,
underlining the importance of building public confidence.
The Government remains committed to learning the lessons from the
Inquiry and to strengthen our preparedness for the future.
I would like to thank and her team for their
work on this report. The Government will consider its findings
and recommendations, working closely with colleagues across the
devolved governments, and respond in due course.
Module 4 Report - Vaccines and
therapeutics
Module 4 Report In-brief summary
- Vaccines and therapeutics
